Screening Potential Drugs for COVID-19 Based on Bound Nuclear Norm Regularization

Screening Potential Drugs for COVID-19 Based on Bound Nuclear Norm Regularization

The novel coronavirus pneumonia COVID-19 infected by SARS-CoV-2 has attracted worldwide attention. It is urgent to find effective therapeutic strategies for stopping COVID-19. In this study, a Bounded Nuclear Norm Regularization (BNNR) method is developed to predict anti-SARS-CoV-2 drug candidates....

Full description

Bibliographic Details
Main Authors:	Juanjuan Wang, Chang Wang, Ling Shen, Liqian Zhou, Lihong Peng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Genetics
Subjects:	SARS-CoV-2 bounded nuclear norm regularization virus-drug association FDA-approved drugs molecular docking
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2021.749256/full

Similar Items

Predict potential miRNA-disease associations based on bounded nuclear norm regularization
by: Yidong Rao, et al.
Published: (2022-08-01)

A review of new drugs approved by the food and drug administration in 2022
by: Arjun Swaminathan, et al.
Published: (2023-01-01)

Identifying potential microRNA biomarkers for colon cancer and colorectal cancer through bound nuclear norm regularization
by: Shengyong Zhai, et al.
Published: (2022-09-01)

Fully automated virtual screening pipeline of FDA-approved drugs using Caver Web
by: Milos Musil, et al.
Published: (2022-01-01)

Drugs, Devices, and the FDA: Part 1
by: Gail A. Van Norman, MD
Published: (2016-04-01)

Drugs and Devices
by: Gail A. Van Norman, MD
Published: (2016-08-01)

Asymmetric Synthesis of US-FDA Approved Drugs over Five Years (2016–2020): A Recapitulation of Chirality
by: Rekha Tamatam, et al.
Published: (2023-02-01)

New estimations on the upper bounds for the nuclear norm of a tensor
by: Xu Kong, et al.
Published: (2018-10-01)

Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study
by: Gema Lizbeth Ramírez-Salinas, et al.
Published: (2020-11-01)

High-Throughput Screening of FDA-Approved Drug Library Reveals Ixazomib Is a Broad-Spectrum Antiviral Agent against Arboviruses
by: Cuiling Ding, et al.
Published: (2022-06-01)

Antiviral effects of micafungin against pteropine orthoreovirus, an emerging zoonotic virus carried by bats
by: Eiichi Hondo, et al.
Published: (2024-01-01)

Facilitating a More Efficient Commercial Review Process for Pediatric Drugs and Biologics
by: Ryan D. Rykhus, et al.
Published: (2017-12-01)

Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes
by: Lorenzo Flori, et al.
Published: (2023-04-01)

A Transcriptomics-Based Bioinformatics Approach for Identification and In Vitro Screening of FDA-Approved Drugs for Repurposing against Dengue Virus-2
by: Madhura Punekar, et al.
Published: (2022-09-01)

Repurposing of drugs for combined treatment of COVID-19 cytokine storm using machine learning
by: Maanaskumar R. Gantla, et al.
Published: (2023-02-01)

A new integrated framework for the identification of potential virus–drug associations
by: Jia Qu, et al.
Published: (2023-08-01)

Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021
by: Alexander C. Martins, et al.
Published: (2022-09-01)

2023 FDA TIDES (Peptides and Oligonucleotides) Harvest
by: Danah Al Shaer, et al.
Published: (2024-02-01)

Carbamazepine alone and in combination with doxycycline attenuates isoproterenol-induced cardiac hypertrophy
by: Harold Ray Garner, et al.
Published: (2010-02-01)

Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery
by: Zhonglei Wang, et al.
Published: (2021-01-01)

Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach
by: Ghazala Muteeb, et al.
Published: (2022-02-01)

Sensor dimer disruption as a new mode of action to block the IRE1-mediated unfolded protein response
by: Kosala N. Amarasinghe, et al.
Published: (2022-01-01)

Currently Available Non-Balloon Devices
by: Hang Lak Lee
Published: (2018-09-01)

FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022
by: Carla Rizzo, et al.
Published: (2023-04-01)

Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies
by: Isidro Palos, et al.
Published: (2017-06-01)

Editorial: Adopting drug repurposing to overcome drug resistance in cancer
by: Eswar Shankar, et al.
Published: (2023-04-01)

Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia
by: Majd A. Al-Hamaly, et al.
Published: (2024-01-01)

Chronological Review and Rational and Future Prospects of Cannabis-Based Drug Development
by: Dvora Namdar, et al.
Published: (2020-10-01)

An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy
by: Juliana T. W. Tong, et al.
Published: (2021-09-01)

Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice
by: Chunfeng Li, et al.
Published: (2017-10-01)

Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-Kinases
by: Daniel A. Rodrigues, et al.
Published: (2019-05-01)

Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of <i>Plasmodium vivax</i> Malaria and Prophylaxis of Malaria
by: Annie Mayence, et al.
Published: (2019-07-01)

A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers
by: Kaifeng Liu, et al.
Published: (2024-03-01)

COVID-19 Treatment—Current Status, Advances, and Gap
by: Chian Ho, et al.
Published: (2022-10-01)

Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug library
by: Jisun Oh, et al.
Published: (2022-08-01)

Structure-Based Virtual Screening and Functional Validation of Potential Hit Molecules Targeting the SARS-CoV-2 Main Protease
by: Balasubramanian Moovarkumudalvan, et al.
Published: (2022-11-01)

Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases
by: Zhan Wang, et al.
Published: (2022-12-01)

Tadalafil Rescues the p.M325T Mutant of Best1 Chloride Channel
by: Kathleen Elverson, et al.
Published: (2023-04-01)

Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library
by: Jie Feng, et al.
Published: (2014-01-01)

Rational drug repurposing for alzheimer’s treatment using in-silico ligand and structure-based approaches
by: Karishma Rathi, et al.
Published: (2024-02-01)